{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:56:37Z","timestamp":1779231397870,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/mph.0000000000000436","type":"journal-article","created":{"date-parts":[[2015,10,10]],"date-time":"2015-10-10T15:54:59Z","timestamp":1444492499000},"page":"e481-e485","source":"Crossref","is-referenced-by-count":30,"title":["Personalized Therapy for Generalized Lymphatic Anomaly\/Gorham-Stout Disease With a Combination of Sunitinib and Taxol"],"prefix":"10.1097","volume":"37","author":[{"given":"Jochen","family":"R\u00f6ssler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Saueressig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"von Winterfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianoula L.","family":"Klement","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20221016","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"R2-19-20221016","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2106\/00004623-195537050-00008","article-title":"Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis","volume":"37-A","author":"Gorham","year":"1955","journal-title":"Bone Joint Surg Am"},{"key":"R3-19-20221016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00361471","article-title":"Seventeen year follow-up and autopsy findings in a case of massive osteolysis","volume":"16","author":"Pastakia","year":"1987","journal-title":"Skeletal Radiol"},{"key":"R4-19-20221016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0901-5027(06)80035-4","article-title":"Massive osteolysis (Gorham-Stout syndrome) in the maxillofacial region: an unusual manifestation","volume":"25","author":"Klein","year":"1996","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R5-19-20221016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1196\/annals.1413.022","article-title":"Gorham\u2019s disease: an osseous disease of lymphangiogenesis?","volume":"1131","author":"Radhakrishnan","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R6-19-20221016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1413.015","article-title":"The clinical spectrum of lymphatic disease","volume":"1131","author":"Radhakrishnan","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R7-19-20221016","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00256-012-1565-4","article-title":"Gorham-Stout disease and generalized lymphatic anomaly\u2014clinical, radiologic, and histologic differentiation","volume":"42","author":"Lala","year":"2013","journal-title":"Skeletal Radiol"},{"key":"R8-19-20221016","first-page":"829","article-title":"Postmenarchal development of chylous ascites in acrocephalosyndactyly with congenital lymphatic dysplasia","volume":"97","author":"Batt","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R9-19-20221016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SCS.0b013e3182413ea8","article-title":"Lymphatic malformation: risk of progression during childhood and adolescence","volume":"23","author":"Hassanein","year":"2012","journal-title":"J Craniofac Surg"},{"key":"R10-19-20221016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-5-3","article-title":"Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009","volume":"5","author":"Heritier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"R11-19-20221016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1631\/jzus.B1200308","article-title":"Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature","volume":"14","author":"Hu","year":"2013","journal-title":"J Zhejiang Univ Sci B"},{"key":"R12-19-20221016","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/lrb.2012.0004","article-title":"Osteolysis and lymphatic anomalies: a review of 54 consecutive cases","volume":"10","author":"Lopez-Gutierrez","year":"2012","journal-title":"Lymphat Res Biol"},{"key":"R13-19-20221016","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/annonc\/mdq331","article-title":"First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham-Stout) with bevacizumab in a child","volume":"21","author":"Grunewald","year":"2010","journal-title":"Ann Oncol"},{"key":"R14-19-20221016","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI8829","article-title":"Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity","volume":"105","author":"Klement","year":"2000","journal-title":"J Clin Invest"},{"key":"R15-19-20221016","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ncponc0660","article-title":"Platelet-derived growth factor receptor-beta in Gorham\u2019s disease","volume":"3","author":"Hagendoorn","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"R16-19-20221016","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.1196\/annals.1413.000","article-title":"The lymphatic continuum revisited","volume":"1131","author":"Rockson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R17-19-20221016","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI71614","article-title":"Genetics of lymphatic anomalies","volume":"124","author":"Brouillard","year":"2014","journal-title":"J Clin Invest"},{"key":"R18-19-20221016","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ajhg.2012.01.003","article-title":"Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB","volume":"90","author":"Zankl","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R19-19-20221016","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/jmg.39.7.478","article-title":"Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24","volume":"39","author":"Brice","year":"2002","journal-title":"J Med Genet"},{"key":"R20-19-20221016","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-0004.2006.00687.x","article-title":"Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations","volume":"70","author":"Ghalamkarpour","year":"2006","journal-title":"Clin Genet"},{"key":"R21-19-20221016","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/cge.12388","article-title":"Hypotrichosis-lymphedema-telangiectasia-renal defect associated with a truncating mutation in the SOX18 gene","volume":"87","author":"Moalem","year":"2015","journal-title":"Clin Genet"},{"key":"R22-19-20221016","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/375614","article-title":"Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia","volume":"72","author":"Irrthum","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R23-19-20221016","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ajmg.1320400223","article-title":"Intestinal lymphangiectasia, lymphedema, mental retardation, and typical face: confirmation of the Hennekam syndrome","volume":"40","author":"Gabrielli","year":"1991","journal-title":"Am J Med Genet"},{"key":"R24-19-20221016","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jcp.2006.038885","article-title":"Microvascular proliferation in congenital vascular malformations of skin and soft tissue","volume":"60","author":"Meijer-Jorna","year":"2007","journal-title":"J Clin Pathol"},{"key":"R25-19-20221016","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.989","article-title":"Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease","volume":"195","author":"Hirayama","year":"2001","journal-title":"J Pathol"},{"key":"R26-19-20221016","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00492472","article-title":"Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease","volume":"87","author":"Dickson","year":"1987","journal-title":"Histochemistry"},{"key":"R27-19-20221016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humpath.2007.04.022","article-title":"Lymphatics and bone","volume":"39","author":"Edwards","year":"2008","journal-title":"Hum Pathol"},{"key":"R28-19-20221016","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R29-19-20221016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2014.12.039","article-title":"Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance","volume":"358","author":"Kareva","year":"2015","journal-title":"Cancer Lett"},{"key":"R30-19-20221016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001813-200301000-00003","article-title":"Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly","volume":"14","author":"Wang","year":"2003","journal-title":"Anticancer Drugs"},{"key":"R31-19-20221016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1013172910858","article-title":"Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches","volume":"20","author":"Kerbel","year":"2001","journal-title":"Cancer Metastasis Rev"},{"key":"R32-19-20221016","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1172\/JCI116450","article-title":"Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis","volume":"91","author":"Shweiki","year":"1993","journal-title":"J Clin Invest"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201511000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T23:01:25Z","timestamp":1665961285000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201511000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000436","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}